Prostate Cancer

Prostate cancer is one of the most common types of cancer in men and may often progress without causing symptoms in the early stages. For this reason, regular check-ups are highly important for early recognition of risks and for the correct diagnostic process. PSA evaluation, physical examination, and advanced imaging methods when necessary help clarify the characteristics of the disease. In the management of prostate cancer, the goal is to create an individualized treatment plan while also preserving quality of life.

What Is Prostate Cancer?

Prostate cancer is a disease that occurs when cells in the prostate gland, located just below the bladder in the male reproductive system, begin to multiply uncontrollably. The prostate is an organ that produces part of the seminal fluid and surrounds the urinary canal. Prostate cancer is often slow-growing; however, some subtypes may behave more aggressively and progress more rapidly. For this reason, prostate cancer should not be considered a single uniform disease, but should be addressed with an individualized risk assessment.

Prostate cancer risk increases with age, making age an important risk factor. A family history of the disease, especially in first-degree relatives, may strengthen the suspicion of genetic predisposition. However, prostate cancer may not always cause symptoms; in fact, many men are evaluated because of elevated PSA levels or abnormal examination findings detected during routine check-ups. Therefore, regular follow-up plays a critical role in identifying suspected prostate cancer at an early stage.

Diagnosis of Prostate Cancer

The diagnostic process in prostate cancer usually begins with the evaluation of the PSA (Prostate-Specific Antigen) level and a digital rectal examination. PSA alone is not a definite indicator of cancer; benign conditions such as prostate enlargement and prostatitis may also raise PSA levels. Even so, the level of PSA elevation, the speed of increase, and age-based interpretation provide important clues for the physician regarding prostate cancer. Feeling hardness, irregularity, or a nodule in the prostate tissue during rectal examination is also among the findings that increase the likelihood of prostate cancer.

One of the most important steps in diagnosis is multiparametric prostate MRI imaging. MRI can show the location and characteristics of suspicious areas within the prostate tissue, thereby helping the biopsy to be performed in a more targeted way.

The diagnosis of prostate cancer is not made by imaging alone; pathology is required to confirm the diagnosis. For this reason, a biopsy is planned when suspicious findings are present. Based on the biopsy result, the grade and extent of the cells are evaluated; classifications such as the Gleason score and Grade Group provide clearer information about the biological behavior of the disease. In this way, correct staging and treatment planning for prostate cancer become possible.

Prostate Fusion Biopsy

Prostate fusion biopsy is an advanced biopsy method that allows suspicious areas seen on multiparametric prostate MRI to be targeted by matching them with ultrasound images. In conventional (systematic) biopsy, standard samples are taken from specific regions of the prostate. In the fusion approach, suspicious areas seen on MRI are marked as targets and the biopsy needle is directed to these focal points. This method can be a valuable option especially in patients who have previously undergone biopsy without a diagnosis despite persistent suspicion of prostate cancer, or in cases where a distinct focus is detected on MRI.

Prostate fusion biopsy aims to increase the likelihood of detecting clinically significant prostate cancer. It may also provide advantages in reducing unnecessary sampling, obtaining tissue from the correct site, and not missing a high-risk focus. Fusion biopsy can be performed through the transrectal or transperineal route; the choice may vary depending on the patient’s clinical features, the center’s experience, and infection risk management. Regardless of the biopsy method, pre-procedure preparation, the antibiotic protocol, and explanation of possible complications are important. Ultimately, the goal is to safely reach the most accurate pathological diagnosis for prostate cancer.

Symptoms of Prostate Cancer

Symptoms in prostate cancer may vary depending on the stage of the disease and its location within the prostate. In the early stage, prostate cancer often causes no symptoms and may be detected incidentally during screening or routine check-ups. In symptomatic cases, the most common complaints are similar to lower urinary tract symptoms. Signs such as frequent urination, waking up at night to urinate, weak urine flow, difficulty starting urination, or a feeling of incomplete emptying may resemble benign prostate enlargement. For this reason, it is not possible to diagnose prostate cancer based only on symptoms; evaluation must always be carried out with a physician’s examination and appropriate tests.

In some cases, blood in the urine, blood in the semen, or a feeling of discomfort in the pelvic region may occur. In more advanced prostate cancer, systemic findings such as bone pain, especially persistent pain in the lower back or hip region, fatigue, and weight loss may accompany the condition. However, since these symptoms can also be seen in many different diseases, the most appropriate approach in suspected prostate cancer is to proceed with a structured diagnostic process.

Hormone therapy aims to control the disease by suppressing androgens, which are effective in the growth of prostate cancer cells. In advanced-stage or metastatic prostate cancer, systemic treatments may come into consideration; the goal here is to slow the course of the disease, preserve quality of life, and reduce complications. In every case, the treatment decision should be clarified through a detailed discussion within the framework of the patient’s expectations and the balance of risks and benefits.

Urinary Incontinence After Cancer Treatment

Urinary incontinence after prostate cancer treatment is one of the topics patients are most curious about, especially after surgery. Urinary control depends on the coordinated function of the sphincter muscles around the prostate and the pelvic floor muscles. Although there are surgical techniques aimed at preserving these structures, urinary leakage may occur in the early period after surgery. In most patients, significant improvement occurs over time; however, the recovery period may vary from person to person.

Urinary complaints may also occur after radiotherapy; irritative symptoms such as frequent urination, sudden urgency, or burning may be more prominent. Pelvic floor muscle exercises have an important place in the management of urinary incontinence after prostate cancer treatment. Exercises planned according to the physician’s recommendation may contribute to strengthening the urinary control mechanism. In persistent cases, additional evaluations are performed, and different treatment approaches may be considered according to the type of complaint. The most appropriate approach here is not to regard any urinary complaint that develops after prostate cancer treatment as normal and simply ignore it, but to address it through regular follow-up. In this way, both quality of life is preserved and the patient’s return to daily life becomes safer and more comfortable.